Background: This paper determines the co-occurrence and correlations of different problem behaviours in children and adolescents in German clinical and general population samples. Sampling and Methods: The 2 samples were matched by age and gender (each sample n = 1,760). Including both categorical and dimensional models, rates of co-occurrence, relative risks, odds ratios and Pearson correlations were calculated. Results: The bidirectional comorbidity rates ranged from 7.3 to 34.3% (epidemiological sample) and from 22.5 to 54.8% (clinical sample). Most correlations between syndrome scales show medium or large effects. Many can be identified as ‘epiphenomenal’; partial correlations from each pair, excluding influences of other syndromes, are much lower. Conclusions: This study shows the cross-cultural generalizability of comorbidity rates. The epiphenomenal nature of some comorbidities warrants future attention.

Keywords:
Problem behaviour, children, adolescents, Comorbidity, Co-occurrence, Child Behaviour Checklist, Epidemiology
This content is only available via PDF.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.